Imaging axonal damage of normal-appearing white matter in multiple sclerosis

Brain

Volumn 121, Issue 1, 1998, Pages 103-113

  Fu, L ^a,b   Matthews, P M ^d   De Stefano, N ^a   Worsley, K J ^c   Narayanan, S ^a   Francis, G S ^a   Antel, J P ^a   Wolfson, C ^b   Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Dept of Epidemiol and Biostatist ^*

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Axons; Magnetic resonance spectroscopy; Multiple sclerosis; Pathology; White matter

Indexed keywords

CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISABILITY; DISEASE COURSE; FUNCTIONAL DISEASE; HUMAN; LONGITUDINAL STUDY; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REMISSION; WHITE MATTER;

EID: 0031962941     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.1.103     Document Type: Article

References (44)

1. Armspach JP, Gounot D, Rumbach L, Chambron J. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 1991; 9: 107-13.
2. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990; 14: 154-9.
3. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992; 31: 235-41.
4. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994; 36: 76-82.
5. Collins DL, Fu L, Pioro EP, Evans AC, Arnold DL. Generation of normal average metabolite images from MRSI in stereotaxic space. Proc Soc Magn Reson Med 1993; 3: 1536.
6. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
7. Davies SE, Newcombe J, Williams SR, McDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995; 64: 742-8.
8. 1H NMR spectroscopic imaging. Proc Soc Magn Reson Med 1991; 1: 472.
9. De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995a; 38: 901-9.
10. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995b; 34: 721-7.
11. Evans AC, Marrett S, Neelin P, Collins L, Worsley K, Dai W, et al. Anatomical mapping of functional activation in stereotactic coordinate space. NeuroImage 1992; 1: 43-53.
12. Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995; 45: 255-60.
13. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RS. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2: 189-210.
14. Fu L, Wolfson C, Worsley KJ, De Stefano N, Collins DL, Narayanan S, et al. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients. NMR Biomed 1996; 9: 339-46
15. Haughton VM, Yetkin FZ, Rao SM, Rimm AA, Fischer ME, Papke RA, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 1992; 26: 71-8.
16. Hiehle JF Jr, Lenkinski RE, Grossman RI, Dousset V, Ramer KN, Schnall MD, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994; 32: 285-93.
17. 1H spectroscopic imaging. Ann Neurol 1994; 36: 157-65.
18. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986; 42: 805-20.
19. Kamber M. Automated detection of multiple sclerosis lesions in magnetic resonance images of the human brain [Master's Thesis]. Montreal: Concordia University, 1991.
20. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston (MA): PWS-Kent, 1988.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
22. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 83: 963-74.
23. Larsson HB, Christiansen P, Jensen M, Frederiksen J, Heltberg A, Olesen J, et al. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 1991; 22: 23-31.
24. Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996; 119: 2009-19.
25. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 9. Amsterdam: North-Holland, 1970: 296-8.
26. 31P NMR spectroscopy. Magn Reson Med 1989; 11: 1-21.
27. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis [published erratum appears in Neurology 1991; 41: 1828]. Neurology 1991; 41: 1251-6.
28. Matthews PM, Cianfaglia L, McLaurin J, Cashman N, Sherwin A, Arnold D, et al. Demonstration of reversible decreases in N-acetylaspartate (NAA) in a neuronal cell line: NAA decreases as a marker of sublethal neuronal dysfunction. Proc Soc Magn Reson Med 1995; 1: 147.
29. Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996; 119: 715-22.
30. McDonald WI, Sears TA. The effects of experimental demyelination on conduction in the central nervous system. Brain 1970; 93: 583-98.
31. Miller DH, Johnson G, Tofts PS, MacManus D, McDonald WI. Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 1989;11: 331-6.
32. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996; 39: 6-16.
33. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41: 385-91.
34. Ordidge RJ, Mansfield P, Lohman JA, Prime SB. Volume selection using gradients and selective pulses. Ann N Y Acad Sci 1987; 508: 376-85.
35. 1H spectroscopic imaging at 4.1 T. Magn Reson Med 1996; 36: 72-7.
36. Paty DW, Li DK, UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7. Comment in : Neurology 1993; 43: 641-3.
37. Paty DW, Li DK, UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7. Comment in : Neurology 1993; 43: 641-3.
38. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
39. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain 1993; 116: 681-93.
40. Rasminsky M. Pathophysiology of demyelination. [Review]. Ann NY Acad Sci 1984; 436: 68-85.
41. Roth K, Kimber BJ, Feeney J. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems. J Magn Reson 1980; 41: 302.
42. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging. Stuttgart: Thieme, 1988.
43. Tofts PS, du Boulay EP. Towards quantitative measurements of relaxation times and other parameters in the brain. Neuroradiology 1990; 32: 407-15.
44. Weiller C, Chollet F, Friston KJ, Wise RJ, Frackowiak RS. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992; 31: 463-72.